Profil
Dr. Ron W.
Lennox is Vice President & Partner at CHL Healthcare Partners.
He is on the Board of Directors at POINT Biomedical Corp., OpGen, Inc., BioRelix, Inc., and BIKAM Pharmaceuticals, Inc.
Dr. Lennox was previously employed as Research Scientist by Johns Hopkins University.
He also served on the board at GeneOhm Sciences, Inc. and PrimeraDx, Inc.
Dr. Lennox graduated from the University of Glasgow with a B.Sc.
in Molecular Biology, Oxford University where he received a D.Phil.
in Cell Biology and the Wharton School of the University of Pennsylvania.
Aktive Positionen von Ron W. Lennox
| Unternehmen | Position | Beginn |
|---|---|---|
BioRelix, Inc.
BioRelix, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of antibiotics | Treasurer | - |
Thetis Pharmaceuticals LLC
Thetis Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug development services | Direktor/Vorstandsmitglied | 07.05.2019 |
Ehemalige bekannte Positionen von Ron W. Lennox
| Unternehmen | Position | Ende |
|---|---|---|
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Direktor/Vorstandsmitglied | - |
| CAPFORCE INC. | Vorsitzender | 02.08.2012 |
POINT Biomedical Corp.
POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology Develops biomedical-imaging products | Direktor/Vorstandsmitglied | - |
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Direktor/Vorstandsmitglied | - |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Ron W. Lennox
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
OpGen, Inc.
OpGen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies against life-threatening, antibiotic-resistant infections using molecular diagnostics and bioinformatics | Commercial Services |
POINT Biomedical Corp.
POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology Develops biomedical-imaging products | Health Technology |
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Health Technology |
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
BioRelix, Inc.
BioRelix, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of antibiotics | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CHL Healthcare Partners LLC
CHL Healthcare Partners LLC Investment ManagersFinance CHL Healthcare Partners invests in companies located in the US. The firm targets companies operating in a broad range of sectors. It provides financing for seed and early stage capital requirements with an investment size ranging from USD 0.1 - 7.5 million. It makes control investments and has a board seat requirements. | Finance |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thetis Pharmaceuticals LLC
Thetis Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug development services | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















